Pharmalot… Pharmalittle… The Weekend Nears
1 CommentBy Ed Silverman // January 15th, 2010 // 8:07 am
Once again, the end of a long week approaches. We hope you survived so far. What are your weekend plans? Catching up on reading or with friends? We will tend to the short and not-so-short people. Before we get ahead of ourselves, however, another day lies ahead. So let’s all grab our cup of stimulation and get started. Meanwhile, have a great weekend, everyone, and see you soon…
Pfizer Hit With Chantix Lawsuits (Reuters)
Wockhardt And Abbott Deal May Be Blocked (LiveMint)
Xenoport Says Restless Legs Drug Won’t Need Panel (Bloomberg News)
FDA: No Heart Risk With Spiriva Inhaler (Associated Press)
Amgen’s Denosumab And Bone Cancer (BusinessWeek)
photo thx to tipiro on Flickr creative commons
JimK
Re: Chantix Lawsuit
Much of the Chantix (varnecline) controversy has abated but the drug still remains among one of the top drugs on the FDA’s quarterly adverse events report (at least as of Qtr IV,2008).
Since Pfizer has stepped up its marketing campaign it will be interesting to see if there is a resurgence in media worthy stories.
http://www.ismp.org/QuarterWatch/2008Q4.pdf